(dailyRx News) Side effects are unfortunately a risk that come with many medications. This week, health officials are warning that an anti-seizure medication has been tied to serious skin reactions.
The epilepsy medication Onfi (clobazam) has been connected with two rare but severe skin conditions.
The US Food and Drug Administration (FDA) has approved label changes for the medication in light of these new findings and asked that patients using the medication be alert for signs of rash.
Read more from RxWiki HERE.
Posted in Industry News